Clinical Laboratories: Turn a Cybersecurity Risk Into a Seamless Upgrade

October 14, 2025

Lab directors and administrators face a critical milestone: Microsoft will end support for Windows 10 on October 14, 2025. After this date, Microsoft will no longer release security updates, leaving systems open to malware and cyberattacks.¹... Read more »

Alcohol Assay from Carolina Liquid Chemistries Receives CLIA Moderate Complexity Categorization on Abbott ImmTox™ 270 Chemistry Analyzer

August 14, 2025

GREENSBORO, NC — (August 14, 2025) — An ethyl alcohol (ETOH) assay from Carolina Liquid Chemistries Corp. (CLC) has been categorized as moderately complex under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for use... Read more »

Carolina Liquid Chemistries Now Offers K-ASSAY® CLIA Moderate Complexity Microalbumin Reagent for Use on the Medica EasyRA® Benchtop Clinical Chemistry Analyzer

November 30, 2023

GREENSBORO, NC — (November 30, 2023) – Carolina Liquid Chemistries Corp. (CLC) has partnered with Kamiya Biomedical Company (Kamiya) to obtain CLIA1 moderate complexity categorization for K-ASSAY® Microalbumin reagent for use on the Medica EasyRA®... Read more »

Drug Screening Assays Now Available on the Diazyme DZ-Lite™ c270 Benchtop Clinical Chemistry Analyzer

September 6, 2023

Making It One of the Most Versatile Analyzers on the Market with an Extensive Test Menu Including General Chemistries, Special Chemistries, and Drug Tests GREENSBORO, NC — (September 6, 2023) – Carolina Liquid Chemistries Corp.... Read more »

Carolina Liquid Chemistries Corp. and Diazyme Laboratories, Inc. Announce Partnership Expanding Test Menu on the Diazyme DZ-Lite™ c270 Benchtop Clinical Chemistry Analyzer, Adding 25 New Assays Totaling Over 45 CLIA Categorized Assays

January 20, 2023

GREENSBORO, NC — (Jan. 20, 2023) – Carolina Liquid Chemistries Corp. (CLC) and Diazyme Laboratories, Inc. (Diazyme) announce a partnership to expand the test menu on the Diazyme DZ-Lite™ c270 benchtop clinical chemistry analyzer. Diazyme,... Read more »

CLC Now Offers Aldolase Assay for Use on Clinical Chemistry Analyzers

November 11, 2019

Reagent Aids in Diagnosis of Myocardial Infarction and Liver Disease GREENSBORO, NC — (November 11, 2019) — Carolina Liquid Chemistries, Corp. (CLC), an innovative leader in clinical diagnostics, announces a new addition to its menu... Read more »

APO A1, APO B and Rheumatoid Factor added to the CLC800 & CLC 1600 Test Menu

August 22, 2018

Carolina Liquid Chemistries Corp. (CLC) has recently added three moderately complex reagents to their already extensive menu of tests for the CLC800 and the CLC1600 clinical chemistry analyzers. The CLC800 is Carolina Liquid Chemistries’ cost-effective... Read more »

CLC Markets Test to Aid in Predicting Coronary Heart Disease

July 20, 2018

Carolina Liquid Chemistries Corp. (CLC) recently added the PLAC® test to their extensive menu of reagents for use on chemistry analyzers. The PLAC Test is an enzyme assay for the in vitro quantitative determination of... Read more »

Carolina Liquid Chemistries Successfully Launches High-Speed Benchtop Analyzer

June 26, 2018

Carolina Liquid Chemistries Corp., known for its clinical chemistry analyzers and reagents, announces the successful launch of Medica Corporation’s high-speed benchtop analyzer, the EasyRA®. The refreshed EasyRA clinical chemistry analyzer now offers double the throughput,... Read more »